FDA Adverse Event Malfunction Summary report: N

ALN VENA CAVA FILTER AND INTRODUCTION KIT

MDR report key: 2814391 · Received October 26, 2012

Report

Report Number
3007080617-2012-00001
Event Type
Malfunction
Date Received
October 26, 2012
Date of Event
August 23, 2012
Report Date
October 24, 2012
Manufacturer
ALN
Product Code
DTK
PMA / PMN Number
K070514
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

EVAL OF THE FILTER RETURN: EVERY PHYSICAL PARAMETERS OF THE FILTER IS CONFORMED TO SPEC EXCEPT THE DIAMETER OF THE FILTER WHICH COULD NOT BEEN CONTROLLED BECAUSE OF MULTIPLE MANIPULATIONS OF THE FILTER. VERIFICATION OF BATCH RECORDS DEMONSTRATE CONFORMITY OF THE FILTER. EVAL OF EVENT'S CAUSES: CAVOGRAPHY PICTURES OF THE INCIDENT WAS EVALUATED BY A EXPERT FRENCH PHYSICIAN, CURRENT USER OF ALN VENA CAVA FILTER. THE PHYSICIAN STATES THAT THE INCIDENT COULD COME FROM: INJECTION PRESSURE OF CONTRAST MEDIUM TOO IMPORTANT AND NO CONFORM TO OUR SPEC AND/OR PRESENCE OF MEGA CAVA (ONLY INDICATION FOR TE BIRD NEST FILTER WHICH WAS IMPLANTED INSTEAD). CONCLUSION: THE FILTER WAS CONFORMED BUT IS NOT INTENDED TO BE IMPLANTED IN MEGA CAVA. INJECTION OF CONTRAST MEDIUM HAS DISLODGED THE FILTER BECAUSE HE WAS NOT VERY WELL ANCHORED IN THE VENA CAVA. FILTER IS NOT IN CAUSE BUT THE SPECIFIC CIRCUMSTANCE OF THE IMPLANTATION: MEGA CAVA AND GREAT PRESSION CAUSED THE ADVERSE EVENT.

Description of Event or Problem · 1

ALN OPTIONAL VENA CAVA FILTER WAS INSERTED WITH NORMAL PROCEDURE WITHOUT ADVERSE EVENT. DURING POSTDEPLOYMENT CAVOGRAPHY THE PRESSURE CHANGE FROM INJECTION THROUGH THE SHEATH CAUSED THE FILTER TO ACUTELY DESTABILIZE AND MIGRATE INFERIORLY. THE FILTER WAS THEN RETRIEVED AND A PERMANENT BIRD NEST FILTER INDICATED FOR MEGA CAVA WAS PLACED INSTEAD.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ALN VENA CAVA FILTER AND INTRODUCTION KIT ICV OPTIONAL FILTER DTK ALN FB.010500 100510

Patients

Seq Age Sex Outcome Treatment
1 56 YR Required Intervention CONTRAST MEDIUM FOR CAVOGRAPHY